{"transactions":[{"id":2149389,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-29T20:02:05.000Z","date":"2022-09-27","kind":"other","acquired":false,"shares":2489682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Golden Seeds Cognition Therapeutics, LLC distributed these shares to its members on a pro rata basis for no consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-020050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299322020050/form4.xml","form_type":"4"}},{"id":2541539,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Simple Agreement for Future Equity","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"price":0,"reported_value":2992382,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Simple Agreement for Future Equity converted into CGTX common stock upon the closing of the issuer's IPO at 80% of the per share offering price of the IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Simple Agreement for Future Equity converted into CGTX common stock upon the closing of the issuer's IPO at 80% of the per share offering price of the IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Simple Agreement for Future Equity converted into CGTX common stock upon the closing of the issuer's IPO at 80% of the per share offering price of the IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":311706},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541538,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"other","acquired":false,"shares":12276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrant expires on the earliest of (i) March 15, 2023, (ii) upon a liquidation, dissolution or winding up of the Company, (iii) the closing of a Sale Transaction (as defined in the warrant), (iv) upon the closing of the issuer's IPO or (v) upon repayment of a promissory note issued in connection with the warrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The warrant expires on the earliest of (i) March 15, 2023, (ii) upon a liquidation, dissolution or winding up of the Company, (iii) the closing of a Sale Transaction (as defined in the warrant), (iv) upon the closing of the issuer's IPO or (v) upon repayment of a promissory note issued in connection with the warrant."}],"balance_after":0,"derivative":{"exercise_price":0.032,"exercise_date":"2016-03-15","expiration_date":"2023-03-15","underlying":"Common Stock","underlying_shares":12276},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541537,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Convertible Preferred Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":1574370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B-1 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B-1 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B-1 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":486742},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541536,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred  Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":4004181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1237959},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541535,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":542496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A-2 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A-2 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A-2 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":167721},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541534,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":884058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Convertible Preferred Stock converted into Cognition Therapeutics, Inc. (\"CGTX\") common stock upon the closing of the issuer's initial public offering (\"IPO\"), as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Convertible Preferred Stock converted into Cognition Therapeutics, Inc. (\"CGTX\") common stock upon the closing of the issuer's initial public offering (\"IPO\"), as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Convertible Preferred Stock converted into Cognition Therapeutics, Inc. (\"CGTX\") common stock upon the closing of the issuer's initial public offering (\"IPO\"), as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":273321},"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541533,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":311706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Simple Agreement for Future Equity converted into CGTX common stock upon the closing of the issuer's IPO at 80% of the per share offering price of the IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":2489691,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541532,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"sale","acquired":false,"shares":33.09,"price":12,"value":397.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On October 13, 2021, the reporting person exercised a warrant to purchase 12,276 shares of CGTX common stock for $0.032 per share. The reporting person paid the exercise price on a cashless basis, resulting in CGTX's withholding of 33.09 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 12,242 shares. The issuer paid cash to the reporting person in lieu of any fractional share amounts."}],"balance_after":2177985,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541531,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"other","acquired":true,"shares":12276,"price":0.032,"value":392.832,"ownership":{"direct":true},"balance_after":2178019,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541530,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":486742,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B-1 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":2165743,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541529,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":1237959,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":1679001,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541528,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":167721,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A-2 Convertible Preferred Stock converted into CGTX common stock upon the closing of the issuer's IPO, as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":441042,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}},{"id":2541527,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":123469,"kind":"organization","name":"Golden Seeds Cognition Therapeutics LLC","position":1,"cik":"0001884796","reported_name":"Golden Seeds Cognition Therapeutics LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-16T01:51:22.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":273321,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Convertible Preferred Stock converted into Cognition Therapeutics, Inc. (\"CGTX\") common stock upon the closing of the issuer's initial public offering (\"IPO\"), as adjusted for a 1-for-3.2345 reverse stock split, and had no expiration."}],"balance_after":273321,"source":{"system":"sec-edgar","filing":"0001104659-21-126904","document":"tm2130061-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126904/tm2130061-7_4seq1.xml","form_type":"4"}}]}